Janux Therapeutics, Inc.
JANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001817713
No open-market purchases or sales by Janux Therapeutics, Inc. insiders were filed in the last 90 days; 197 institutions reported holding it in 13F filings for Q2 2026, worth $933.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Janux Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +15 vs. Q2 2021
- Shares held
- 26.5M
- +1.76M (+7.1%) vs. Q2 2021
- Total value
- $571.2M
- −$43.3M (−7.0%) vs. Q2 2021
- New holders
- 24
- 9 more added
- Sold out
- 9
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 197 | $933.4M |
| Q1 2026 | 190 | $827.8M |
| Q4 2025 | 176 | $860.0M |
| Q3 2025 | 174 | $1.59B |
| Q2 2025 | 174 | $1.51B |
| Q1 2025 | 181 | $1.81B |
| Q4 2024 | 216 | $3.43B |
| Q3 2024 | 160 | $2.07B |
| Q2 2024 | 155 | $1.87B |
| Q1 2024 | 121 | $1.59B |
| Q4 2023 | 64 | $359.5M |
| Q3 2023 | 57 | $354.0M |
| Q2 2023 | 54 | $362.1M |
| Q1 2023 | 48 | $369.5M |
| Q4 2022 | 50 | $381.3M |
| Q3 2022 | 49 | $400.3M |
| Q2 2022 | 44 | $353.0M |
| Q1 2022 | 47 | $407.1M |
| Q4 2021 | 46 | $541.6M |
| Q3 2021 | 45 | $571.2M |
| Q2 2021 | 30 | $614.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Janux Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 74 | $2.00K | 0.00% | +74 | New |
| Evolution Wealth Advisors, LLC | 124 | $3.00K | 0.00% | +124 | New |
| Tower Research Capital LLC (TRC) | 522 | $11.0K | 0.00% | +522 | New |
| Ameritas Investment Partners, Inc. | 1,014 | $22.0K | 0.00% | +1,014 | New |
| Legal & General Group Plc | 1,239 | $27.0K | 0.00% | +1,239 | New |
| Citigroup Inc | 1,755 | $38.0K | 0.00% | −84,940−98.0% | Reduced |
| New York State Common Retirement Fund | 2,300 | $50.0K | 0.00% | +2,300 | New |
| Royal Bank of Canada | 2,837 | $61.0K | 0.00% | +1,537+118.2% | Added |
| Bank of America Corp | 2,943 | $63.0K | 0.00% | +895+43.7% | Added |
| STRS Ohio | 3,000 | $64.0K | 0.00% | +3,000 | New |
| UBS Group AG | 3,500 | $76.0K | 0.00% | +3,147+891.5% | Added |
| Metropolitan Life Insurance Co | 4,011 | $86.8K | 0.00% | +4,011 | New |
| MetLife Investment Management | 5,302 | $114.7K | 0.00% | +5,302 | New |
| JPMorgan Chase & Co | 6,474 | $140.0K | 0.00% | +5,828+902.2% | Added |
| Morgan Stanley | 6,702 | $145.0K | 0.00% | +6,602+6,602.0% | Added |
| California State Teachers Retirement System | 7,149 | $155.0K | 0.00% | +7,149 | New |
| American International Group, Inc. | 7,242 | $157.0K | 0.00% | +7,242 | New |
| Deutsche Bank AG | 8,185 | $178.0K | 0.00% | +8,185 | New |
| Chicago Partners Investment Group LLC | 9,458 | $235.0K | 0.02% | +9,458 | New |
| Rhumbline Advisers | 11,110 | $240.0K | 0.00% | +11,110 | New |
| Nuveen Asset Management, LLC | 19,457 | $421.0K | 0.00% | +19,457 | New |
| Parkwood LLC | 20,777 | $449.0K | 0.08% | +20,777 | New |
| Bank of New York Mellon Corp | 31,473 | $681.0K | 0.00% | +31,473 | New |
| Charles Schwab Investment Management Inc | 32,576 | $705.0K | 0.00% | +32,576 | New |
| Janney Montgomery Scott LLC | 40,860 | $884.0K | 0.00% | +40,860 | New |
| D. E. Shaw & Co., Inc. | 46,156 | $998.0K | 0.00% | +46,156 | New |
| Parametric Portfolio Associates LLC | 59,366 | $1.28M | 0.00% | +59,366 | New |
| SG Americas Securities, LLC | 65,414 | $1.42M | 0.01% | +65,414 | New |
| Northern Trust Corp | 116,961 | $2.53M | 0.00% | +116,961 | New |
| State Street Corp | 174,644 | $3.78M | 0.00% | +174,644 | New |
| Geode Capital Management, LLC | 211,880 | $4.58M | 0.00% | +189,863+862.3% | Added |
| Logos Global Management LP | 247,122 | $4.81M | 0.35% | −300,000−54.8% | Reduced |
| Woodline Partners LP | 300,031 | $6.49M | 0.11% | −34,229−10.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 400,000 | $8.65M | 0.02% | −50,000−11.1% | Reduced |
| Samsara BioCapital, LLC | 411,871 | $8.91M | 1.48% | −196,078−32.3% | Reduced |
| 5AM Venture Management, LLC | 446,266 | $9.65M | 1.96% | 00.0% | Unchanged |
| Vanguard Group Inc | 530,242 | $11.5M | 0.00% | +501,266+1,729.9% | Added |
| BlackRock Inc. | 801,778 | $17.3M | 0.00% | +691,831+629.2% | Added |
| BVF Inc | 1,017,314 | $22.0M | 0.86% | −159,367−13.5% | Reduced |
| EcoR1 Capital, LLC | 1,411,975 | $30.5M | 1.08% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,859,246 | $39.6M | 0.04% | −27,466−1.5% | Reduced |
| Janus Henderson Group PLC | 2,416,404 | $51.4M | 0.02% | −251,803−9.4% | Reduced |
| OrbiMed Advisors LLC | 3,466,386 | $75.0M | 0.83% | 00.0% | Unchanged |
| FMR LLC | 3,615,431 | $78.2M | 0.01% | +1,771,867+96.1% | Added |
| Ra Capital Management, L.P. | 8,670,644 | $187.5M | 2.60% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −75,257−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −69,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −57,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −32,100−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −24,567−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,309−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −9,165−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −7−100.0% | Sold out |